BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25858293)

  • 1. Acute myeloid leukaemia: challenges and real world data from India.
    Philip C; George B; Ganapule A; Korula A; Jain P; Alex AA; Lakshmi KM; Sitaram U; Abubacker FN; Abraham A; Viswabandya A; Srivastava VM; Srivastava A; Balasubramanian P; Mathews V
    Br J Haematol; 2015 Jul; 170(1):110-7. PubMed ID: 25858293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating blood stream infections during induction chemotherapy in children with acute myeloid leukemia: Single center results in India.
    Subburaj D; Uppuluri R; Jayaraman D; Vellaichamyswaminathan V; Kandath S; Raj R
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28332765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
    Schnegg-Kaufmann A; Feller A; Baldomero H; Rovo A; Manz MG; Gregor M; Efthymiou A; Bargetzi M; Hess U; Spertini O; Chalandon Y; Passweg JR; Stussi G; Arndt V; Bonadies N;
    Cancer Epidemiol; 2018 Feb; 52():55-62. PubMed ID: 29223104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
    Kadia TM; Reville PK; Borthakur G; Yilmaz M; Kornblau S; Alvarado Y; Dinardo CD; Daver N; Jain N; Pemmaraju N; Short N; Wang SA; Tidwell RSS; Islam R; Konopleva M; Garcia-Manero G; Ravandi F; Kantarjian HM
    Lancet Haematol; 2021 Aug; 8(8):e552-e561. PubMed ID: 34329576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center.
    Jain H; Rengaraj K; Sharma V; Bonda A; Chanana R; Thorat J; Ronghe A; Biswas S; Nayak L; Tembhare P; Subramnian P; Shetty D; Patkar N; Bagal B; Sengar M
    JCO Glob Oncol; 2020 Nov; 6():1684-1695. PubMed ID: 33156719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.
    Rubnitz JE; Inaba H; Dahl G; Ribeiro RC; Bowman WP; Taub J; Pounds S; Razzouk BI; Lacayo NJ; Cao X; Meshinchi S; Degar B; Airewele G; Raimondi SC; Onciu M; Coustan-Smith E; Downing JR; Leung W; Pui CH; Campana D
    Lancet Oncol; 2010 Jun; 11(6):543-52. PubMed ID: 20451454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute myeloid leukemia: an Indian perspective.
    Kulkarni KP; Marwaha RK
    Pediatr Hematol Oncol; 2011 May; 28(4):257-68. PubMed ID: 21214409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country.
    Ghafoor T; Khalil S; Farah T; Ahmed S; Sharif I
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1259. PubMed ID: 33085844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
    Lazzarotto D; Candoni A; Nadali G; Pavan L; Lessi F; Mosna F; Simeone E; Ventura G; Gherlinzoni F; Semenzato G; Pizzolo G; Fanin R
    Eur J Haematol; 2016 Jun; 96(6):586-92. PubMed ID: 26186084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
    Thuler LCS; Pombo-de-Oliveira MS
    Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
    Lancet JE; Uy GL; Newell LF; Lin TL; Ritchie EK; Stuart RK; Strickland SA; Hogge D; Solomon SR; Bixby DL; Kolitz JE; Schiller GJ; Wieduwilt MJ; Ryan DH; Faderl S; Cortes JE
    Lancet Haematol; 2021 Jul; 8(7):e481-e491. PubMed ID: 34171279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
    Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
    Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.
    Mendes FR; da Silva WF; da Costa Bandeira de Melo R; Silveira DRA; Velloso EDRP; Rocha V; Rego EM
    Ann Hematol; 2022 Jan; 101(1):147-154. PubMed ID: 34676435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.